GSK, Britain’s second-biggest drugmaker, has unveiled better-than-expected results for the first three months of the year, ahead of the planned July listing of its consumer healthcare division, which makes Sensodyne toothpaste and Panadol painkillers.
Go ahead
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más: